News & Blog

20 years ago genetic testing wasn’t available meaning parents would have to face the complications and challenges that come with having a child with a genetically inherited disease. However, with new medical technology advances, parents can now undergo genetic screening to determine if a couple’s combined DNA carries genes that could cause rare diseases or birth defects. Currently, testing is o...

Researchers at Binghamton University in New York have developed a skin-inspired, open-mesh electromechanical sensor capable of monitoring lactate and oxygen on the skin. The wearable sensor is designed to mimic the skin's elasticity and is embedded with flexible gold sensor cables, allowing for real-time monitoring of wound healing without causing any inflammation to the wound. Binghamton Unive...

Saturated oxygen treatment for heart attack wins FDA approval A new option for treating heart attacks has been awarded approval by the FDA. Currently, left anterior descending ST-elevation myocardial infarctions (LAD STEMI), the most serious type of heart attack, are typically treated by placing a stent in the narrowed artery, or percutaneous coronary intervention (PCI) Now, a method developed ...

SniffPhone is a handheld device capable of detecting early-stage gastric cancer from a person’s exhaled breath. Currently in its prototype phase, the patient holds the device in front of their mouth and simply exhales on to it. SniffPhone then measures the Volatile Organic Compounds (VOCs) contained within the breath using highly sensitive nanotechnology chemical sensors. The measurements are t...

Implantable Eye Microsensor Receives CE mark Implandata Opthalmic has received CE Mark approval for its Eyemate-IO 1.1 microsensor. The device allows permanent implantable eye pressure sensors to be placed in the eye whilst undergoing cataract surgery simultaneously. The sensor continuously monitors the eye pressure in glaucoma patients, providing vital information for guided therapy. Professor...

As medical technology becomes more and more connected, the risks of security breaches in networked devices has become an important issue, with cybersecurity at the forefront for manufacturers. Only last week, US security specialists, Clever Security, discovered flaws in Medtronic's Conexus Radio Frequency Telemetry Protocol and found the device lacked any type of secure communication encryption...

First Cardiac Contractility Modulation Device Approved by FDA Impulse Dynamics, based in Orangeburg, New York has received FDA approval for its cardiac contractility modulation device. The Optimizer smart system, which was previously given "breakthrough device" in 2015 and gained CE Mark approval in 2016, uses three electrode leads to deliver electrical pulses directly to the heart during the m...

The EHRA-Congress 2019 was one of the most important meetings of experts in the field of cardiac arrhythmias. During the three-day conference, industry visitors gained new insights into emerging technologies and the current state of research in arrhythmias, pacing and electrophysiology. The congress was attended by more than 2,000 medical professionals, scientists and key professionals in the w...

Researchers at The University of Western Australia have designed a device that can measure the stiffness and elasticity of biological tissue. The wearable probe can be mounted on the finger and provides high-resolution images of breast tissue by measuring the reflections of light. The drive behind the research is to enable more precise breast cancer removal. Approx. 20 - 30% of patients that un...

BIOTRONIK Wins FDA Approval for Two High-Voltage Families of Cardiac Implants BIOTRONIK'S Acticor and Rivacor high voltage cardiac rhythm implants have received FDA approval. The implants, designed to treat tachycardia are equipped with a new BIOshape and are said to be less irritating on tissues. They also have a longer battery life and up to 15 year lifetime meaning fewer replacement procedur...